Haemorrhage due to thrombin inhibitor other than heparin (Q39586): Difference between revisions

← Older edit

@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/836204111
@@ Property / Canonical URI: https://id.who.int/icd/entity/836204111 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:3B21.0
@@ Property / CURIE: CID11:3B21.0 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-3B21.0
@@ Property / Canary Token: dki-india-3B21.0 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+D68.3
@@ Property / Linked ICD 10: D68.3 / rank @@
+Normal rank

Latest revision as of 05:04, 13 August 2026

A disease caused by any thrombin inhibitors other than heparin that affects normal coagulation of the blood. This disease is characterised by inability of the blood to coagulate leading to bleeding. Confirmation is by identification of thrombin inhibitors in a blood sample.

Language	Label	Description	Also known as
default for all languages	3B21.0
English	Haemorrhage due to thrombin inhibitor other than heparin	A disease caused by any thrombin inhibitors other than heparin that affects normal coagulation of the blood. This disease is characterised by inability of the blood to coagulate leading to bleeding. Confirmation is by identification of thrombin inhibitors in a blood sample.